Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/G1SK34 stock hub

BVMF/G1SK34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/G1SK34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

491B

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/G1SK34

In the news

Latest news · BVMF/G1SK34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.9

P25 11.3P50 14.6P75 19.6

Trailing P/E12.2

P25 15.2P50 21.5P75 27.3

ROE40.9

P25 5.3P50 12.3P75 22.5

ROIC26.7

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/G1SK34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

GBP

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	BR
Employees	66,841
Employees Change	-1,583%
Employees Change Percent	-2.25
Enterprise value	BRL 592.7B
Exchange	Brazil Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	BRL 491B
Price	BRL 49.05
Price currency	BRL
Rev Per Employee	3,378,260.46x
Sector	Healthcare
Sic	2834
Symbol	bvmf/G1SK34
Website	https://www.gsk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.18%
EV Earnings	14.76x
EV/EBIT	8.97x
EV/EBITDA	7.63x
EV/FCF	13.49x
EV/Sales	2.71x
FCF yield	8.95%
Forward P/E	9.86x
P/B ratio	4.09x
P/E ratio	12.23x
P/S ratio	2.17x
PE Ratio10 Y	90.22x
PE Ratio3 Y	14.7x
PE Ratio5 Y	13.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.22%
EBITDA Margin	34.88%
FCF margin	19.45%
Gross margin	72.87%
Gross Profit	BRL 164.5B
Gross Profit Growth	5.34%
Gross Profit Growth Q	2.97%
Gross Profit Growth3 Y	5.29%
Gross Profit Growth5 Y	3.18%
Net Income	BRL 40.2B
Net Income Growth	84.87%
Net Income Growth Q	6.96%
Net Income Growth3 Y	-26.44%
Net Income Growth5 Y	2.09%
Pretax Margin	22.69%
Profit Margin	17.78%
Profit Per Employee	BRL 600,728
ROA	10.02
Roa5y	7.23
ROCE	24.49
ROE	40.91
Roe5y	32.1
ROIC	26.7
Roic5y	22.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	21.27%
Cagr3y	15.73%
Div CAGR3	-66.35%
EPS Growth	86.56
EPS Growth Q	8.4
EPS Growth3 Y	-26.53
EPS Growth5 Y	1.74
FCF Growth	18.47%
FCF Growth Q	-1.81%
FCF Growth3 Y	19.56%
FCF Growth5 Y	-0.62%
OCF Growth	14.78%
OCF Growth Q	-0.35%
OCF Growth10 Y	11.09%
OCF Growth3 Y	16.34%
OCF Growth5 Y	-0.18%
Revenue Growth	3.97x
Revenue Growth Q	1.5x
Revenue Growth3 Y	4.07x
Revenue Growth5 Y	1.68x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.53
Assets	BRL 433.1B
Cash	BRL 23.7B
Current Assets	BRL 119B
Current Liabilities	BRL 150.3B
Debt	BRL 131.7B
Debt EBITDA	BRL 1.64
Debt Equity	BRL 1.1
Debt FCF	BRL 3
Equity	BRL 120B
Interest Coverage	14.94
Liabilities	BRL 313.1B
Long Term Assets	BRL 314.1B
Long Term Liabilities	BRL 162.8B
Net Cash	BRL -107.9B
Net Cash By Market Cap	BRL -21.98
Net Debt EBITDA	BRL 1.37
Net Debt Equity	BRL 0.9
Net Debt FCF	BRL 2.46
Tangible Book Value	BRL -52.2B
Tangible Book Value Per Share	BRL -12.98
WACC	5.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.79
Inventory Turnover	1.46
Net Working Capital	BRL -21.1B
Quick ratio	0.51
Working Capital	BRL -32.2B
Working Capital Turnover	BRL -60.91

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.13%
Dividend Growth	5.74%
Dividend Growth Years	2%
Dividend per share	BRL 1.8
Dividend Years	5
Dividend Yield	3.68%
Ex Div Date	2026-02-19
Last Dividend	BRL 0.46
Payout Frequency	Quarterly
Payout Ratio	18.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	21.25%
200-day SMA	48.41
3Y total return	55.02%
50-day SMA	56.73
50-day SMA vs 200-day SMA	50over200
All Time High	63.24
All Time High Change	-20.78%
All Time High Date	2026-02-20
All Time Low	30.69
All Time Low Change	63.25%
All Time Low Date	2022-09-22
ATR	1.03
Beta	0.3
Ch YTD	-7.65
High	49.22
High52	63.24
High52 Date	2026-02-20
High52ch	-22.44%
Low	49.05
Low52	39.98
Low52 Date	2025-07-17
Low52ch	22.69%
Ma50ch	-11.69%
Price vs 200-day SMA	3.48%
RSI	23.75
RSI Monthly	53.29
RSI Weekly	43.21
Sharpe ratio	0.63x
Sortino ratio	1.14
Total Return	4.8%
Tr YTD	-6.91
Tr1m	-12.93%
Tr1w	0.8%
Tr3m	-19.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 68.2B
Operating Income Growth	59.89
Operating Income Growth Q	19.83
Operating Income Growth3 Y	10.08
Operating Income Growth5 Y	6.55
Operating margin	30.22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,864,337,078%
Net Borrowing	3,570,850,181.5
Shares Insiders	0.07%
Shares Institutions	86.82%
Shares Qo Q	-0.29%
Shares Yo Y	-1.13%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 41.3B
Average Volume	25x
Bv Per Share	30.59
CAPEX	BRL -9.4B
Ch1m	-12.93
Ch1w	0.8
Ch1y	16.65
Ch3m	-19.87
Ch3y	38.06
Ch6m	0.1
Change	-2.1%
Change From Open	-0.3
Close	50.1
Days Gap	-1.8
Depreciation Amortization	10,236,883,822.3
Dollar Volume	5,444.5
Earnings Date	2026-04-29
EBIT	BRL 68.2B
EBITDA	BRL 78.8B
EPS	BRL 9.78
F Score	7
FCF	BRL 43.9B
FCF EV Yield	7.41x
Financing CF	-29,420,949,915
Fiscal Year End	December
Founded	1,715
Goodwill	48,819,484,563.3
Graham Number	32.8954
Graham Upside	-32.93
Income Tax	BRL 7.4B
Investing CF	-31,377,294,981
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	BRL 20.06
Lynch Upside	-59.11
Ma150	49.99
Ma150ch	0.22%
Ma20	55.08
Ma20ch	-9.04%
Net CF	-7,542,950,166
Next Earnings Date	2026-07-29
Open	49.2
P FCF Ratio	11.18
P OCF Ratio	9.21
Payment Date	2026-04-15
Position In Range	0
Ppne	67,249,895,162.2
Price Date	2026-05-08
Price EBITDA	BRL 6.23
Relative Volume	4.44x
Revenue	225,806,307,240x
SBC By Revenue	1.14x
Share Based Comp	2,576,313,573
Tax By Revenue	3.3x
Tax Rate	14.54%
Tr6m	1.79%
Volume	111
Z Score	2.09

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/G1SK34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.7%

$1.80 annual per share

Payout ratio

+18.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

+4.8%

Next ex-dividend date: 2026-02-19

Performance

BVMF/G1SK34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/G1SK34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+86.8%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.1%

Negative means the company is buying back shares.

Technical

BVMF/G1SK34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

23.7

Below 30: short-term oversold

Price vs 200-day MA

+3.5%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/G1SK34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/G1SK34 stock rating?

bvmf/G1SK34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/G1SK34 analysis?

The full report lives at /stocks/bvmf/G1SK34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/G1SK34?

The latest report frames bvmf/G1SK34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/G1SK34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.